Post-marketing surveillance has documented cases of inadvertent overdosing, typically involving administration errors where patients received higher-than-prescribed doses or more frequent injections than intended
Researchers who optimize their nutrition while on GLP-1 peptides tend to see better results at lower doses
[1] [2] Extensive clinical trial data from the SURPASS program (for diabetes) and SURMOUNT trials (for weight management) involving thousands of participants did not identify epistaxis as a significant adverse event associated with tirzepatide use
doi: 10.1007/s11695-025-07703-0, Summary Keywords content characteristics, creator identity, information quality, semaglutide, short-video platforms, side effects Citation Song J, He X, Cui Z, Sun Y, Liu Y, Yu H, Li A and Jin M (2026) Quality and reliability of semaglutide content on different Chinese short video platforms: a study focusing on side effects
CJC 1295 is a synthetic analog of the natural hormone GHRH, which signals the pituitary gland to release growth hormone
Other common experiences include constipation in 24% of users and occasional digestive upset